Cargando…
Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines
A large number of different types of cancer have been shown to be associated with an abnormal metabolism of phosphatidylcholine (PC), the main component of eukaryotic cell membranes. Indeed, the overexpression of choline kinase α1 (ChoKα1), the enzyme that catalyses the bioconversion of choline to p...
Autores principales: | García-Molina, Pablo, Sola-Leyva, Alberto, Luque-Navarro, Pilar M., Laso, Alejandro, Ríos-Marco, Pablo, Ríos, Antonio, Lanari, Daniela, Torretta, Archimede, Parisini, Emilio, López-Cara, Luisa C., Marco, Carmen, Carrasco-Jiménez, María P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876215/ https://www.ncbi.nlm.nih.gov/pubmed/35214160 http://dx.doi.org/10.3390/pharmaceutics14020426 |
Ejemplares similares
-
Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors
por: Luque-Navarro, Pilar María, et al.
Publicado: (2022) -
Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors
por: Schiaffino-Ortega, Santiago, et al.
Publicado: (2021) -
New Compounds with Bioisosteric Replacement of Classic Choline Kinase Inhibitors Show Potent Antiplasmodial Activity
por: Aguilar-Troyano, Francisco José, et al.
Publicado: (2021) -
Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells
por: Sola-Leyva, Alberto, et al.
Publicado: (2019) -
Choline and Choline alphoscerate Do Not Modulate Inflammatory Processes in the Rat Brain
por: Tayebati, Seyed Khosrow, et al.
Publicado: (2017)